Figure 9. Immunotherapy analysis. (A, B) Gene expression of immune checkpoint molecules and pyroptosis-related genes in high- and low-risk groups. (C) GSVA analysis telling which functions or pathways were active in high- and low-risk groups with * indicated correlation, green indicated negative correlation, and red indicated positive correlation. (D–G) Immunotherapy analysis to compare the effect of immunotherapy in high- and low-risk groups. (H–K) Drug sensitivity analysis of various drugs differences between high- and low-risk groups with p-value < 0.05 indicating a difference.